June 8 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab said on Monday it will acquire biotech Firefly Bio for $1 billion in cash, as it looks to expand its cancer drug pipeline. Firefly's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results